A preliminary retrospective analysis of weekly topotecan in recurrent smallcell lung cancer.

被引：0
|
作者：
Kasturi, VK
Eckardt, JR
Greco, FA
机构：
[1] Dartmouth Hitchcock Keene Kingsbury Ctr Canc Care, Keene, NH USA
[2] St Johns Mercy Med Ctr, St Louis, MO 63141 USA
[3] Sarah Cannon Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7359
引用
收藏
页码：705S / 705S
页数：1
相关论文
共 50 条
  • [31] Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis
    Imai, Hisao
    Yamada, Yutaka
    Minemura, Hiroyuki
    Sugiyama, Tomohide
    Kotake, Mie
    Kaira, Kyoichi
    Kanazawa, Kenya
    Nakamura, Yoichi
    Kasai, Takashi
    Shibata, Yoko
    Kaburagi, Takayuki
    Minato, Koichi
    THORACIC CANCER, 2018, 9 (12) : 1699 - 1706
  • [32] Weekly topotecan as first-line treatment for recurrent or persistent epithelial ovarian cancer (EOC).
    Safra, T
    Menczer, J
    Inbar, M
    En-Shem, E
    Glezerman, M
    Grisaro, D
    Ron, I
    Levy, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 482S - 482S
  • [33] A preliminary report of a phase II study of weekly topotecan in platinum-sensitive recurrent ovarian and peritoneal carcinoma
    Rodriguez, M
    Method, MW
    Lewandowski, G
    Vaccarello, L
    Ansari, RH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 464S - 464S
  • [34] Dose and schedule finding study of oral topotecan (T) in combination with weekly cisplatin (C) ± cremophor EL (CrEl) in patients (pts) with recurrent ovarian cancer.
    Gelderblom, AJ
    Sparreboom, A
    de Jonge, MJA
    Loos, WJ
    Hennis, B
    Verweij, J
    van der Burg, MEL
    CLINICAL CANCER RESEARCH, 2000, 6 : 4515S - 4515S
  • [35] A phase I/II study of topotecan in combination with Carboplatin in recurrent epithelial ovarian cancer.
    Scarfone, G
    Parazzini, F
    Sciatta, C
    Polverino, GP
    Rosa, C
    Guarnerio, P
    Bolis, G
    ANNALS OF ONCOLOGY, 2000, 11 : 86 - 86
  • [36] Phase II study of weekly topotecan in patients with relapsed platinum-sensitive ovarian or peritoneal cancer.
    Morris, RT
    Alvarez, RD
    Malone, J
    Bryant, C
    Andrews, SJ
    Kilgore, L
    Phibbs, GD
    Heilbrun, L
    Munkarah, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 468S - 468S
  • [37] Safety of topotecan in the treatment of recurrent small-cell lung cancer and ovarian cancer
    Garst, Jennifer
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (01) : 53 - 62
  • [38] Postmarketing surveillance study on the use of topotecan in small-cell lung cancer. Use of topotecan in a pneumology university department
    Hureaux, J.
    Alizon, C.
    Urban, T.
    REVUE DES MALADIES RESPIRATOIRES, 2012, 29 (05) : 680 - 687
  • [39] Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer
    Jaime Coronel
    Lucely Cetina
    Myrna Candelaria
    Aurora González-Fierro
    Daimy Arias
    David Cantu
    Alfonso Dueñas-González
    Medical Oncology, 2009, 26 : 210 - 214
  • [40] Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer
    Gelderblom, H
    Sparreboom, A
    de Jonge, MJA
    Loos, WJ
    Wilms, E
    Mantel, MA
    Hennis, B
    Camlett, I
    Verweij, J
    van der Burg, MEL
    BRITISH JOURNAL OF CANCER, 2001, 85 (08) : 1124 - 1129
12345